This study supports the National Asthma Education and Prevention Program guidelines for step-up therapy with LABAs for asthma that is uncontrolled on low-dose ICS. The study was not large enough ...
Trelegy Ellipta, a triple-therapy inhaler containing an inhaled corticosteroid (ICS), a long-acting muscarinic antagonist (LAMA), and a long-acting beta-agonist (LABA), was found to offer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback